Medical/Pharmaceuticals

CES 2021 MedFluid Develops First-In-Class Microfluidic Platform for Rapid Detection and Screening of Disease Diagnosis

TAIPEI, Taiwan, Jan. 17, 2021 /PRNewswire/ -- Health and Biotech company MedFluid has developed the fastest, first-in-class antimicrobial susceptibility test that will aid in providing precise medical prescriptions to improve the health and well-being of patients.

2021-01-17 18:02 1851

COVID-19 vaccines: Common solution, not competition

BEIJING, Jan. 15, 2021 /PRNewswire/ -- A news report by China.org.cn on China's COVID-19 vaccines:   At the end of 2020, one of China's self-developed COVID-19 vaccines was granted conditional approval for general use by the National Medical Products Administration. Previously,...

2021-01-15 22:01 4388

Senhwa Biosciences Presents Positive Cholangiocarcinoma Data

TAIPEI and SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announces that promising clinical data from their global phase...

2021-01-15 22:00 2652

Gracell Biotechnologies Receives Medical Products Manufacturing Certificate for CAR-T Cell Therapy Products

SUZHOU, China, Jan. 15, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, has been granted the Medical Products Manuf...

2021-01-15 21:00 2703

Modern Chinese Medicine Group Co., Ltd. Trading Debut Closed at HK$1.26 Per Share

HONG KONG, Jan. 15, 2021 /PRNewswire/ -- Modern Chinese Medicine Group Co., Ltd. ("Modern Chinese Medicine", together with its subsidiaries, the "Group"; stock code: 1643), which principally engages in the production of proprietary Chinese medicine (the "PCM") and offers both over-the-counter (the...

2021-01-15 18:57 12722

CES 2021 Taiwanese Startup ACSI Gives New Technological Shine to Traditional Chinese Medical Treatments

TAIPEI, Jan. 15, 2021 /PRNewswire/ -- Chinese medicine has been receiving increased attention worldwide. These traditional therapeutic treatments are now being combined with modern technology and integrated into Western medicine. Acupuncture, for example, is being widely adopted and trusted by pa...

2021-01-15 14:35 1576

Hyde Engineering + Consulting Announces Appointment of Chief Executive Officer

Kerren Bergman Promoted to Lead Hyde's Global Corporation BOULDER, Colo., Jan. 15, 2021 /PRNewswire/ -- Hyde Engineering + Consulting, Inc. (Hyde) a worldwide partner for solution-based pharmaceutical design and consulting services, announced the appointment of Kerren Bergman as Chief Executive ...

2021-01-15 00:48 11449

Nonin Medical Announces New Full Board of Directors

MINNEAPOLIS, Jan. 14, 2021 /PRNewswire/ -- Nonin Medical announced the appointment of four new members to the company's board of directors. Each of the new directors brings unique industry experience and passion for innovation in the medtech and healthcare sectors. Together, they will provide Non...

2021-01-14 21:51 2566

Huami to Host 2021 Strategy and Outlook Investor Fireside Chat with CEO Wang Huang on January 22

BEIJING, Jan. 14, 2021 /PRNewswire/ -- Huami Corp. (NYSE: HMI) today announced that it will hold a Fireside Chat conference call for investors on Friday,22 January 2021. The company will discuss its 2021 strategies for consumer and industrial health technologies, including its product plans annou...

2021-01-14 19:00 10355

Modern Chinese Medicine Group Co., Ltd. announces its subscription results

HONG KONG, Jan. 14, 2021 /PRNewswire/ -- Modern Chinese Medicine Group Co., Ltd. ("Modern Chinese Medicine", together with its subsidiaries, the "Group"; stock code: 1643), which principally engages in the production of proprietary Chinese medicine (the "PCM") and offers both over-the-counter (the...

2021-01-14 14:30 9902

Ascentage Pharma Presents Updates on its Global Clinical Development at the J.P. Morgan 39th Annual Healthcare Conference

SUZHOU, China and ROCKVILLE, Md., Jan. 14, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, presented at the J.P. Morgan 39th Annual Hea...

2021-01-14 09:32 2246

RapidAI Receives 2020 Global Company of the Year Award From Frost & Sullivan for its AI-Powered Stroke Imaging and Diagnosis Technologies

RapidAI's products empower physicians with accurate information to make the right decision at the right time, leading to improved patient outcomes SANTA CLARA, Calif., Jan. 13, 2021 /PRNewswire/ -- Based on its recent analysis of the global AI-based stroke imaging and diagnosis market, Frost & ...

2021-01-13 23:21 1626

Butterfly Network and Access Afya Recognized by the World Bank Group-CES Global Tech Challenge for Work Around Solving for Accessible, Affordable Healthcare through Innovative Telehealth Model in Kenya

GUILFORD, Conn., Jan. 13, 2021 /PRNewswire/ -- Butterfly Network, Inc., an innovative digital health company that is working to enable universal access to superior medical imaging, is proud to partner with Access Afya in advancing health care on the ground inKenya, facilitated by TechEmerge He...

2021-01-13 21:22 5602

Caliber Ophthalmics Opens New State-of-the-Art Ophthalmology Center of Excellence

SINKING SPRING, Pa., Jan. 13, 2021 /PRNewswire/ -- Caliber Ophthalmics, a Surgical Specialties Corporation company, is pleased to announce the opening of a state of the art ophthalmology design and manufacturingCenter of Excellence in Sinking Spring, PA. The newly renovated 23,000 square foot faci...

2021-01-13 21:07 2509

ATIF Holdings Limited Announces Its IPO Client Soars 100% in the U.S. Trading Debut

LOS ANGELES, Jan. 13, 2021 /PRNewswire/ -- ATIF Holdings Limited (Nasdaq: ATIF, "ATIF"), a company providing business consulting and media services in Asia and North America, announces the client ofATIF, a China-based pharmaceutical and chemical products manufacturer, Qilian International Holding...

2021-01-13 21:00 9722

China NMPA Grants Approval for the Registrational Phase 1/2 Clinical Study for GC007g - an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL

SUZHOU and SHANGHAI, China, Jan. 13, 2021 /PRNewswire/ --  Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, has been granted approval fo...

2021-01-13 21:00 1403

The Sigourney Award-2020 Honors Four Recipients With Distinguished Independent Prize for Advancing Psychoanalysis and Psychoanalytic Thought

SEATTLE, Jan. 13, 2021 /PRNewswire/ -- A panel of distinguished judges evaluated a record number of applications received from 13 countries for The Sigourney Award-2020 and have selected four winners. Today,William A. Myerson, Ph.D., MBA, and psychoanalyst co-trustee ofThe Sigourney Trust, ann...

2021-01-13 21:00 1432

GenScript Submits Application with FDA for Use of cPass™ SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening

PISCATAWAY, N.J., Jan. 13, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading research reagent provider, announced today that it has submitted an application to the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 N...

2021-01-13 20:30 5161

Mentice to enhance its organization with several new key positions

STOCKHOLM, Jan. 13, 2021 /PRNewswire/ -- Mentice AB (publ), a leading supplier of high-tech solutions for simulation in the medical sector, with focus on endovascular procedures, has announced changes to its organization. Several new key positions have been created, aimed at improving Mentice's r...

2021-01-13 20:19 1061

Holmusk, National Healthcare Group and Institute of Mental Health outline strategic collaboration to strengthen mental healthcare in Singapore

SINGAPORE, Jan. 13, 2021 /PRNewswire/ -- Holmusk has signed a Memorandum of Understanding (MOU) withSingapore's National Healthcare Group (NHG) and the Institute of Mental Health (IMH), to jointly develop innovative solutions for mental healthcare. The MOU outlines a shared vision to use digital ...

2021-01-13 14:43 2621
1 ... 432433434435436437438 ... 578